These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 3584483

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Biliary excretion of plasma non-transferrin-bound iron in rats: pathogenetic importance in iron-overload disorders.
    Brissot P, Zanninelli G, Guyader D, Zeind J, Gollan J.
    Am J Physiol; 1994 Jul; 267(1 Pt 1):G135-42. PubMed ID: 8048526
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of iron-chelator deferiprone on the in vitro growth of staphylococci.
    Kim CM, Shin SH.
    J Korean Med Sci; 2009 Apr; 24(2):289-95. PubMed ID: 19399272
    [Abstract] [Full Text] [Related]

  • 30. Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools.
    Hoyes KP, Porter JB.
    Br J Haematol; 1993 Oct; 85(2):393-400. PubMed ID: 8280612
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin-4-ones CP20 and CP94.
    Chenoufi N, Hubert N, Loréal O, Morel I, Pasdeloup N, Cillard J, Brissot P, Lescoat G.
    J Hepatol; 1995 Aug; 23(2):166-73. PubMed ID: 7499788
    [Abstract] [Full Text] [Related]

  • 37. Mobilisation of iron from peritoneal rat macrophages by desferrioxamine.
    Kleber EE, Torrance JD, Bothwell TH, Simon MO, Charlton RW.
    Scand J Haematol; 1981 Sep; 27(3):209-18. PubMed ID: 7313547
    [Abstract] [Full Text] [Related]

  • 38. Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.
    Zevin S, Link G, Grady RW, Hider RC, Peter HH, Hershko C.
    Blood; 1992 Jan 01; 79(1):248-53. PubMed ID: 1728313
    [Abstract] [Full Text] [Related]

  • 39. EPR study of antioxidant activity of the iron chelators pyoverdin and hydroxypyrid-4-one in iron-loaded hepatocyte culture: comparison with that of desferrioxamine.
    Morel I, Sergent O, Cogrel P, Lescoat G, Pasdeloup N, Brissot P, Cillard P, Cillard J.
    Free Radic Biol Med; 1995 Feb 01; 18(2):303-10. PubMed ID: 7744315
    [Abstract] [Full Text] [Related]

  • 40. In vivo evaluation of hydroxypyridone iron chelators in a mouse model.
    Gyparaki M, Porter JB, Hirani S, Streater M, Hider RC, Huehns ER.
    Acta Haematol; 1987 Feb 01; 78(2-3):217-21. PubMed ID: 3120475
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.